AUTUMN WESTMORELAND: Open Payments
NPI 1114544509 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 59 payments from 17 companies in 2025. Trend: 2023 $996 · 2024 $997 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $509 |
| PFIZER INC. | 15 | $199 |
| Novo Nordisk Inc | 12 | $181 |
| Kestra Medical Technology Services, Inc. | 3 | $133 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $73 |
| Boston Scientific Corporation | 2 | $64 |
| Alnylam Pharmaceuticals Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: Rapiblyk, VYNDAQEL, Assure WCD, Wegovy, LEQVIO, LifeVest, ONPATTRO, Ozempic.
Industry payments across WA — which companies pay providers there.
